(News Bulletin 247) – Berenberg raised Thursday from 88 to 90 Swiss francs its target price on Alcon stock, which it continues to recommend for purchase.

From the analyst’s point of view, the second quarter results published by the world leader in ophthalmology have confirmed that the latter benefited from a favorable dynamic.

‘Even more importantly, the publication showed clear signs that the group is making progress on its strategic objectives, whether in markets such as eye health, contact lenses or the treatment of cataracts,” he adds.

In the shorter term, the intermediary believes that the 2023 forecasts communicated by the Swiss group are cautious and that its estimates could be revised upwards by the end of the year.

Copyright (c) 2023 News Bulletin 247. All rights reserved.